High‑affinity cyclic peptides can be identified for GPCRs, multi‑pass membrane proteins, and other transmembrane targets. A cell‑based screening approach enables evaluation in functionally relevant target states and helps address limitations of conventional discovery methods.
Download the technical overview to review target applicability, workflow, and representative case examples.
Explore Fujifilm's cell-based screening platform for GPCRs and other transmembrane targets.
Key topics covered:
- Target applicability
- Screening workflow
- FGFR & GPCR case examples
- Discovery track record
Screen from a library of more than 10¹³ peptide variants.
Our cell-based screening platform enables exploration of diverse peptide candidates against transmembrane protein targets.
Cell-based screening identified selective peptide hits for GPCR and other transmembrane protein targets.
See the Technical Overview for the screening workflow and representative FGFR and GPCR case examples.
Selected findings have also been presented at TIDES USA 2026.
Review representative FGFR and GPCR case examples, screening workflow, and target applicability.
Discuss applicability to your target, including GPCRs, transmembrane proteins, and other difficult-to-screen targets.